Saccharomyces Cerevisiae (Baker's/Brewer's Yeast) for Blood Sugar Regulation

Research suggests that baker's yeast beta-glucan, a dietary fiber component derived from Saccharomyces cerevisiae, may support blood sugar regulation in the context of obesity and diabetes. The available evidence comes from a single preclinical animal study conducted in 2017, which found that oral administration of yeast beta-glucan lowered blood glucose levels and reduced liver accumulation of glucose and lipids in diabetic mice, apparently by influencing key metabolic signaling pathways and reducing intestinal absorption of sugars and fats. While these findings are mechanistically interesting and suggest a plausible basis for further investigation, the evidence base is currently limited to animal research, and it is not yet known whether these effects translate to humans. Controlled human trials would be necessary before stronger conclusions can be drawn about the role of baker's yeast or its components in blood sugar management.